Nagaokakyo, Japan

Hiroshi Shimizu

This inventor holds 1 USPTO granted patent. Top assignee: Ono Pharmaceutical Co., Ltd.. Active years: 1977.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hiroshi Shimizu. Retrieved from https://idiyas.com/inventor/hiroshi-shimizu-60nylgs5

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1977

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hiroshi Shimizu: Innovator in Cholesterol Oxidase Production

Introduction

Hiroshi Shimizu is a notable inventor based in Nagaokakyo, Japan. He has made significant contributions to the field of biochemistry, particularly in the production of cholesterol oxidase. His innovative approach has led to advancements in various applications, including medical and pharmaceutical research.

Latest Patents

Hiroshi Shimizu holds a patent for a process for producing cholesterol oxidase. This process involves cultivating Schizophyllum commune (IFO 4928) in a culture medium and extracting the cholesterol oxidase from the culture filtrate. This patent showcases his expertise and dedication to enhancing biochemical processes.

Career Highlights

Shimizu is currently employed at Ono Pharmaceutical Co., Ltd., where he continues to work on innovative projects. His role at the company allows him to collaborate with other experts in the field and contribute to the development of new pharmaceutical solutions.

Collaborations

Throughout his career, Hiroshi Shimizu has worked alongside talented colleagues, including Mamoru Sugiura and Masayasu Sugiyama. These collaborations have fostered a creative environment that encourages the exchange of ideas and the pursuit of groundbreaking research.

Conclusion

Hiroshi Shimizu's contributions to the field of cholesterol oxidase production highlight his innovative spirit and commitment to advancing biochemistry. His work continues to impact the pharmaceutical industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…